Ferreycorp S.A.A. (BVL:FERREYC1)

Ligand Pharmaceuticals Balance Sheet

Financials in millions PEN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	176.82	248.26	219.1	192.02	215.76	256.19
Cash & Short-Term Investments	176.82	248.26	219.1	192.02	215.76	256.19
Cash Growth	-4.94%	13.31%	14.10%	-11.01%	-15.78%	173.31%
Accounts Receivable	1,083	1,159	1,345	1,292	1,015	975.25
Receivables	1,083	1,159	1,345	1,292	1,015	975.25
Inventory	2,377	2,520	2,256	2,207	2,082	1,684
Prepaid Expenses	-	32.06	33.99	39.59	40.26	32.86
Other Current Assets	235.73	214.81	202.53	223.56	213.87	270.98
Total Current Assets	3,872	4,174	4,057	3,955	3,566	3,219
Property, Plant & Equipment	2,187	2,079	1,826	1,648	1,700	1,630
Long-Term Investments	36.78	34.34	23.32	20.7	19.75	18.01
Goodwill	153.82	155.84	156.46	159.15	180.1	174.87
Other Intangible Assets	167.76	181.28	208.76	231.18	257.62	279.37
Long-Term Accounts Receivable	29.28	27.08	36.8	37.92	40.66	61.49
Long-Term Deferred Tax Assets	193.81	192.51	177.25	151.1	174.73	221.87
Other Long-Term Assets	7.01	23.24	40.09	46.02	48.69	33.33
Total Assets	6,648	6,868	6,525	6,249	5,987	5,638
Accounts Payable	624.36	670.52	791.98	782.41	782.17	500.54
Short-Term Debt	1,071	983.57	1,210	746.99	438.61	466.46
Current Portion of Long-Term Debt	314.83	342.92	353.29	364.3	264.67	330.36
Current Portion of Leases	17.6	21.16	26.97	37.14	41.78	42.83
Current Income Taxes Payable	12.52	15.71	23.49	51.34	71.57	44.92
Other Current Liabilities	598.67	710.37	553.12	547.4	613.45	884.68
Total Current Liabilities	2,639	2,744	2,959	2,530	2,212	2,270
Long-Term Debt	846.35	1,005	751.88	1,048	1,184	912.77
Long-Term Leases	36.11	46.01	16.41	41.73	78.6	99.16
Long-Term Unearned Revenue	0.89	0.73	2.66	5.74	7.21	0.4
Long-Term Deferred Tax Liabilities	135.28	136.48	129.01	133.29	162.48	195.2
Other Long-Term Liabilities	2.36	2.18	1.65	2.28	1.01	0.16
Total Liabilities	3,660	3,935	3,860	3,760	3,645	3,477
Common Stock	946.06	946.06	946.06	946.06	958.89	975.68
Additional Paid-In Capital	52.41	52.41	27.74	42.52	43.71	55.55
Retained Earnings	1,451	1,591	1,362	1,150	976.92	787.24
Treasury Stock	-	-	-12.31	-1.1	-12.83	-17.8
Comprehensive Income & Other	537.98	344.09	341.15	350.69	375.46	351.93
Total Common Equity	2,988	2,933	2,665	2,488	2,342	2,153
Minority Interest	-	-	-	-	-	8.3
Shareholders' Equity	2,988	2,933	2,665	2,488	2,342	2,161
Total Liabilities & Equity	6,648	6,868	6,525	6,249	5,987	5,638
Total Debt	2,286	2,399	2,358	2,238	2,007	1,852
Net Cash (Debt)	-2,109	-2,150	-2,139	-2,046	-1,792	-1,595
Net Cash Per Share	-2.24	-2.29	-2.28	-2.18	-1.89	-1.66
Filing Date Shares Outstanding	946.06	946.06	921.93	944.96	946.06	957.88
Total Common Shares Outstanding	946.06	946.06	921.93	944.96	946.06	957.88
Working Capital	1,233	1,430	1,098	1,425	1,354	949.58
Book Value Per Share	3.16	3.10	2.89	2.63	2.48	2.25
Tangible Book Value	2,666	2,596	2,300	2,098	1,904	1,698
Tangible Book Value Per Share	2.82	2.74	2.49	2.22	2.01	1.77
Land	693.61	682.29	678.38	600.41	667.03	612.65
Buildings	626.5	543.65	514.76	479.76	494.27	445.24
Machinery	1,797	1,435	1,365	1,191	1,098	1,038
Construction In Progress	36.32	124.57	11.78	18.66	54.1	47.04

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.